Analyze Diet
Biochemical and biophysical research communications2007; 362(2); 347-353; doi: 10.1016/j.bbrc.2007.07.182

Characterization and differentiation of equine umbilical cord-derived matrix cells.

Abstract: Stem cells are being evaluated in numerous human clinical trials and are commercially used in veterinary medicine to treat horses and dogs. Stem cell differentiation, homing to disease sites, growth and cytokine factor modulation, and low antigenicity contribute to their therapeutic success. Bone marrow and adipose tissue are the two most common sources of adult-derived stem cells in animals. We report on the existence of an alternative source of primitive, multipotent stem cells from the equine umbilical cord cellular matrix (Wharton's jelly). Equine umbilical cord matrix (EUCM) cells can be cultured, cryogenically preserved, and differentiated into osteo-, adipo-, chondrogenic, and neuronal cell lineages. These results identify a source of stem cells that can be non-invasively collected at birth and stored for future use in that horse or used as donor cells for treating unrelated horses.
Publication Date: 2007-08-13 PubMed ID: 17719011DOI: 10.1016/j.bbrc.2007.07.182Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Journal Article

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

This research article discusses the finding of a new source of primitive, multipotent stem cells from equine umbilical cord cellular matrix (known as Wharton’s jelly), which can be differentiated into various cell lineages and can be used non-invasively in treatments of horses.

Stem Cells in Clinical Trials and Veterinary Medicine

  • The article begins by outlining the importance of stem cells in human clinical trials and in veterinary medicine, particularly in treatments for horses and dogs. Stem cells offer various therapeutic benefits due to their ability to differentiate, attract to sites of disease, proliferate, modulate growth and cytokine factors, and offer low antigenicity (which helps to decrease immune responses).
  • The primary sources of adult-derived stem cells in animals are usually bone marrow and adipose (fat) tissue. However, these sources often require invasive procedures to extract.

Equine Umbilical Cord Matrix as a Stem Cell Source

  • However, this research identifies the equine umbilical cord cellular matrix (specifically, a substance called Wharton’s jelly) as an alternative source of primitive, multipotent stem cells.
  • The researchers suggest that the stem cells from this source, referred to as EUCM cells, can be non-invasively collected at birth and stored for future use.

Characteristics and Differentiation Capacity of EUCM Cells

  • The results of the research showed that EUCM cells can be cultivated in the lab and preserved through cryogenic methods (freezing at very low temperatures).
  • Hello, EUCM cells were found to be capable of differentiating into a number of different cell types, specifically osteogenic (bone-forming), adipogenic (fat-forming), chondrogenic (cartilage-forming), and neuronal (nerve) cell lineages.

Potential Applications of EUCM Cells

  • The discovery of this new source of stem cells could have significant therapeutic implications for the treatment of horses. For example, they could potentially be used to repair bone, cartilage, fat, or nerve tissue in injured or diseased horses.
  • Because these cells can be collected non-invasively at birth and stored, they can be available for use at any point in a horse’s life, providing a convenient and versatile medical resource.

Cite This Article

APA
Hoynowski SM, Fry MM, Gardner BM, Leming MT, Tucker JR, Black L, Sand T, Mitchell KE. (2007). Characterization and differentiation of equine umbilical cord-derived matrix cells. Biochem Biophys Res Commun, 362(2), 347-353. https://doi.org/10.1016/j.bbrc.2007.07.182

Publication

ISSN: 0006-291X
NlmUniqueID: 0372516
Country: United States
Language: English
Volume: 362
Issue: 2
Pages: 347-353

Researcher Affiliations

Hoynowski, Steven M
  • Department of Pharmacology and Toxicology, University of Kansas, 1251 Wescoe Hall Drive, Malott Rm 5064, Lawrence, KS 66045-7582, USA.
Fry, Madeline M
    Gardner, Bryn M
      Leming, Matthew T
        Tucker, Jeanell R
          Black, Linda
            Sand, Theodore
              Mitchell, Kathy E

                MeSH Terms

                • Adipocytes / chemistry
                • Adipocytes / cytology
                • Adipocytes / metabolism
                • Adipogenesis
                • Alkaline Phosphatase / metabolism
                • Animals
                • Anthraquinones / chemistry
                • Azo Compounds / chemistry
                • Cell Cycle
                • Cell Differentiation
                • Cell Proliferation
                • Cells, Cultured
                • Chondrocytes / chemistry
                • Chondrocytes / cytology
                • Chondrocytes / metabolism
                • Chondrogenesis
                • Female
                • Flow Cytometry
                • Horses
                • Immunohistochemistry
                • Multipotent Stem Cells / chemistry
                • Multipotent Stem Cells / cytology
                • Multipotent Stem Cells / metabolism
                • Neurons / chemistry
                • Neurons / cytology
                • Neurons / metabolism
                • Osteocytes / chemistry
                • Osteocytes / cytology
                • Osteocytes / metabolism
                • Osteogenesis
                • Umbilical Cord / cytology
                • Umbilical Cord / metabolism

                Citations

                This article has been cited 43 times.
                1. Prządka P, Buczak K, Frejlich E, Gąsior L, Suliga K, Kiełbowicz Z. The Role of Mesenchymal Stem Cells (MSCs) in Veterinary Medicine and Their Use in Musculoskeletal Disorders.. Biomolecules 2021 Aug 2;11(8).
                  doi: 10.3390/biom11081141pubmed: 34439807google scholar: lookup
                2. Ribitsch I, Oreff GL, Jenner F. Regenerative Medicine for Equine Musculoskeletal Diseases.. Animals (Basel) 2021 Jan 19;11(1).
                  doi: 10.3390/ani11010234pubmed: 33477808google scholar: lookup
                3. Ramallo M, Carreras-Sánchez I, López-Fernández A, Vélez R, Aguirre M, Feldman S, Vives J. Advances in translational orthopaedic research with species-specific multipotent mesenchymal stromal cells derived from the umbilical cord.. Histol Histopathol 2021 Jan;36(1):19-30.
                  doi: 10.14670/HH-18-249pubmed: 32914860google scholar: lookup
                4. MacDonald ES, Barrett JG. The Potential of Mesenchymal Stem Cells to Treat Systemic Inflammation in Horses.. Front Vet Sci 2019;6:507.
                  doi: 10.3389/fvets.2019.00507pubmed: 32039250google scholar: lookup
                5. Al Naem M, Bourebaba L, Kucharczyk K, Röcken M, Marycz K. Therapeutic mesenchymal stromal stem cells: Isolation, characterization and role in equine regenerative medicine and metabolic disorders.. Stem Cell Rev Rep 2020 Apr;16(2):301-322.
                  doi: 10.1007/s12015-019-09932-0pubmed: 31797146google scholar: lookup
                6. Świstowska M, Gil-Kulik P, Krzyżanowski A, Bielecki T, Czop M, Kwaśniewska A, Kocki J. Potential Effect of SOX2 on the Cell Cycle of Wharton's Jelly Stem Cells (WJSCs).. Oxid Med Cell Longev 2019;2019:5084689.
                  doi: 10.1155/2019/5084689pubmed: 31281582google scholar: lookup
                7. Shojaee A, Parham A. Strategies of tenogenic differentiation of equine stem cells for tendon repair: current status and challenges.. Stem Cell Res Ther 2019 Jun 18;10(1):181.
                  doi: 10.1186/s13287-019-1291-0pubmed: 31215490google scholar: lookup
                8. Moon GJ, Cho YH, Kim DH, Sung JH, Son JP, Kim S, Cha JM, Bang OY. Serum-mediated Activation of Bone Marrow-derived Mesenchymal Stem Cells in Ischemic Stroke Patients: A Novel Preconditioning Method.. Cell Transplant 2018 Mar;27(3):485-500.
                  doi: 10.1177/0963689718755404pubmed: 29774769google scholar: lookup
                9. Barboni B, Russo V, Berardinelli P, Mauro A, Valbonetti L, Sanyal H, Canciello A, Greco L, Muttini A, Gatta V, Stuppia L, Mattioli M. Placental Stem Cells from Domestic Animals: Translational Potential and Clinical Relevance.. Cell Transplant 2018 Jan;27(1):93-116.
                  doi: 10.1177/0963689717724797pubmed: 29562773google scholar: lookup
                10. Olivera R, Moro LN, Jordan R, Pallarols N, Guglielminetti A, Luzzani C, Miriuka SG, Vichera G. Bone marrow mesenchymal stem cells as nuclear donors improve viability and health of cloned horses.. Stem Cells Cloning 2018;11:13-22.
                  doi: 10.2147/SCCAA.S151763pubmed: 29497320google scholar: lookup
                11. Dwivedi G, Chevrier A, Hoemann CD, Buschmann MD. Bone Marrow Progenitor Cells Isolated from Young Rabbit Trochlea Are More Numerous and Exhibit Greater Clonogenic, Chondrogenic, and Osteogenic Potential than Cells Isolated from Condyles.. Cartilage 2018 Oct;9(4):378-390.
                  doi: 10.1177/1947603517693044pubmed: 29156978google scholar: lookup
                12. Rink BE, Amilon KR, Esteves CL, French HM, Watson E, Aurich C, Donadeu FX. Isolation and characterization of equine endometrial mesenchymal stromal cells.. Stem Cell Res Ther 2017 Jul 12;8(1):166.
                  doi: 10.1186/s13287-017-0616-0pubmed: 28701175google scholar: lookup
                13. Esteves CL, Sheldrake TA, Mesquita SP, Pesántez JJ, Menghini T, Dawson L, Péault B, Donadeu FX. Isolation and characterization of equine native MSC populations.. Stem Cell Res Ther 2017 Apr 18;8(1):80.
                  doi: 10.1186/s13287-017-0525-2pubmed: 28420427google scholar: lookup
                14. Zahedi M, Parham A, Dehghani H, Mehrjerdi HK. Stemness Signature of Equine Marrow-derived Mesenchymal Stem Cells.. Int J Stem Cells 2017 May 30;10(1):93-102.
                  doi: 10.15283/ijsc16036pubmed: 28222255google scholar: lookup
                15. Fellows CR, Matta C, Zakany R, Khan IM, Mobasheri A. Adipose, Bone Marrow and Synovial Joint-Derived Mesenchymal Stem Cells for Cartilage Repair.. Front Genet 2016;7:213.
                  doi: 10.3389/fgene.2016.00213pubmed: 28066501google scholar: lookup
                16. Olivera R, Moro LN, Jordan R, Luzzani C, Miriuka S, Radrizzani M, Donadeu FX, Vichera G. In Vitro and In Vivo Development of Horse Cloned Embryos Generated with iPSCs, Mesenchymal Stromal Cells and Fetal or Adult Fibroblasts as Nuclear Donors.. PLoS One 2016;11(10):e0164049.
                  doi: 10.1371/journal.pone.0164049pubmed: 27732616google scholar: lookup
                17. Williams LB, Co C, Koenig JB, Tse C, Lindsay E, Koch TG. Response to Intravenous Allogeneic Equine Cord Blood-Derived Mesenchymal Stromal Cells Administered from Chilled or Frozen State in Serum and Protein-Free Media.. Front Vet Sci 2016;3:56.
                  doi: 10.3389/fvets.2016.00056pubmed: 27500136google scholar: lookup
                18. Somal A, Bhat IA, B I, Pandey S, Panda BS, Thakur N, Sarkar M, Chandra V, Saikumar G, Sharma GT. A Comparative Study of Growth Kinetics, In Vitro Differentiation Potential and Molecular Characterization of Fetal Adnexa Derived Caprine Mesenchymal Stem Cells.. PLoS One 2016;11(6):e0156821.
                  doi: 10.1371/journal.pone.0156821pubmed: 27257959google scholar: lookup
                19. Gomiero C, Bertolutti G, Martinello T, Van Bruaene N, Broeckx SY, Patruno M, Spaas JH. Tenogenic induction of equine mesenchymal stem cells by means of growth factors and low-level laser technology.. Vet Res Commun 2016 Mar;40(1):39-48.
                  doi: 10.1007/s11259-016-9652-ypubmed: 26757735google scholar: lookup
                20. Sasao T, Fukuda Y, Yoshida S, Miyabara S, Kasashima Y, Kuwano A, Arai K. Population doubling level-dependent change of secreted glycosaminoglycan in equine bone marrow-derived mesenchymal stem cells.. J Equine Sci 2015;26(3):73-80.
                  doi: 10.1294/jes.26.73pubmed: 26435680google scholar: lookup
                21. Maia L, da Cruz Landim-Alvarenga F, Taffarel MO, de Moraes CN, Machado GF, Melo GD, Amorim RM. Feasibility and safety of intrathecal transplantation of autologous bone marrow mesenchymal stem cells in horses.. BMC Vet Res 2015 Mar 15;11:63.
                  doi: 10.1186/s12917-015-0361-5pubmed: 25879519google scholar: lookup
                22. Martino NA, Reshkin SJ, Ciani E, Dell'Aquila ME. Calcium-sensing receptor-mediated osteogenic and early-stage neurogenic differentiation in umbilical cord matrix mesenchymal stem cells from a large animal model.. PLoS One 2014;9(11):e111533.
                  doi: 10.1371/journal.pone.0111533pubmed: 25379789google scholar: lookup
                23. Corradetti B, Correani A, Romaldini A, Marini MG, Bizzaro D, Perrini C, Cremonesi F, Lange-Consiglio A. Amniotic membrane-derived mesenchymal cells and their conditioned media: potential candidates for uterine regenerative therapy in the horse.. PLoS One 2014;9(10):e111324.
                  doi: 10.1371/journal.pone.0111324pubmed: 25360561google scholar: lookup
                24. Taha MF, Javeri A, Rohban S, Mowla SJ. Upregulation of pluripotency markers in adipose tissue-derived stem cells by miR-302 and leukemia inhibitory factor.. Biomed Res Int 2014;2014:941486.
                  doi: 10.1155/2014/941486pubmed: 25147827google scholar: lookup
                25. Cadby JA, Buehler E, Godbout C, van Weeren PR, Snedeker JG. Differences between the cell populations from the peritenon and the tendon core with regard to their potential implication in tendon repair.. PLoS One 2014;9(3):e92474.
                  doi: 10.1371/journal.pone.0092474pubmed: 24651449google scholar: lookup
                26. Barberini DJ, Freitas NP, Magnoni MS, Maia L, Listoni AJ, Heckler MC, Sudano MJ, Golim MA, da Cruz Landim-Alvarenga F, Amorim RM. Equine mesenchymal stem cells from bone marrow, adipose tissue and umbilical cord: immunophenotypic characterization and differentiation potential.. Stem Cell Res Ther 2014 Feb 21;5(1):25.
                  doi: 10.1186/scrt414pubmed: 24559797google scholar: lookup
                27. Mohanty N, Gulati BR, Kumar R, Gera S, Kumar P, Somasundaram RK, Kumar S. Immunophenotypic characterization and tenogenic differentiation of mesenchymal stromal cells isolated from equine umbilical cord blood.. In Vitro Cell Dev Biol Anim 2014 Jun;50(6):538-48.
                  doi: 10.1007/s11626-013-9729-7pubmed: 24414976google scholar: lookup
                28. Guest DJ, Ousey JC, Smith MR. Defining the expression of marker genes in equine mesenchymal stromal cells.. Stem Cells Cloning 2008;1:1-9.
                  doi: 10.2147/sccaa.s3824pubmed: 24198500google scholar: lookup
                29. Gittel C, Brehm W, Burk J, Juelke H, Staszyk C, Ribitsch I. Isolation of equine multipotent mesenchymal stromal cells by enzymatic tissue digestion or explant technique: comparison of cellular properties.. BMC Vet Res 2013 Oct 29;9:221.
                  doi: 10.1186/1746-6148-9-221pubmed: 24168625google scholar: lookup
                30. Kang JG, Park SB, Seo MS, Kim HS, Chae JS, Kang KS. Characterization and clinical application of mesenchymal stem cells from equine umbilical cord blood.. J Vet Sci 2013;14(3):367-71.
                  doi: 10.4142/jvs.2013.14.3.367pubmed: 23820166google scholar: lookup
                31. Singh J, Mann A, Kumar D, Duhan JS, Yadav PS. Cultured buffalo umbilical cord matrix cells exhibit characteristics of multipotent mesenchymal stem cells.. In Vitro Cell Dev Biol Anim 2013 Jun;49(6):408-16.
                  doi: 10.1007/s11626-013-9617-1pubmed: 23708916google scholar: lookup
                32. Bongso A, Fong CY. The therapeutic potential, challenges and future clinical directions of stem cells from the Wharton's jelly of the human umbilical cord.. Stem Cell Rev Rep 2013 Apr;9(2):226-40.
                  doi: 10.1007/s12015-012-9418-zpubmed: 23233233google scholar: lookup
                33. Coli A, Nocchi F, Lamanna R, Iorio M, Lapi S, Urciuoli P, Scatena F, Giannessi E, Stornelli MR, Passeri S. Isolation and characterization of equine amnion mesenchymal stem cells.. Cell Biol Int Rep (2010) 2011 Sep 13;18(1):e00011.
                  doi: 10.1042/CBR20110004pubmed: 23124164google scholar: lookup
                34. Spaas JH, Guest DJ, Van de Walle GR. Tendon regeneration in human and equine athletes: Ubi Sumus-Quo Vadimus (where are we and where are we going to)?. Sports Med 2012 Oct 1;42(10):871-90.
                  doi: 10.1007/BF03262300pubmed: 22963225google scholar: lookup
                35. Ryan JM, Pettit AR, Guillot PV, Chan JK, Fisk NM. Unravelling the pluripotency paradox in fetal and placental mesenchymal stem cells: Oct-4 expression and the case of The Emperor's New Clothes.. Stem Cell Rev Rep 2013 Aug;9(4):408-21.
                  doi: 10.1007/s12015-011-9336-5pubmed: 22161644google scholar: lookup
                36. Corradetti B, Lange-Consiglio A, Barucca M, Cremonesi F, Bizzaro D. Size-sieved subpopulations of mesenchymal stem cells from intervascular and perivascular equine umbilical cord matrix.. Cell Prolif 2011 Aug;44(4):330-42.
                37. Raabe O, Shell K, Würtz A, Reich CM, Wenisch S, Arnhold S. Further insights into the characterization of equine adipose tissue-derived mesenchymal stem cells.. Vet Res Commun 2011 Aug;35(6):355-65.
                  doi: 10.1007/s11259-011-9480-zpubmed: 21614641google scholar: lookup
                38. Maurya DK, Doi C, Pyle M, Rachakatla RS, Davis D, Tamura M, Troyer D. Non-random tissue distribution of human naïve umbilical cord matrix stem cells.. World J Stem Cells 2011 Apr 26;3(4):34-42.
                  doi: 10.4252/wjsc.v3.i4.34pubmed: 21607135google scholar: lookup
                39. Martino NA, Lange-Consiglio A, Cremonesi F, Valentini L, Caira M, Guaricci AC, Ambruosi B, Sciorsci RL, Lacalandra GM, Reshkin SJ, Dell'Aquila ME. Functional expression of the extracellular calcium sensing receptor (CaSR) in equine umbilical cord matrix size-sieved stem cells.. PLoS One 2011 Mar 17;6(3):e17714.
                  doi: 10.1371/journal.pone.0017714pubmed: 21437284google scholar: lookup
                40. Lovati AB, Corradetti B, Lange Consiglio A, Recordati C, Bonacina E, Bizzaro D, Cremonesi F. Comparison of equine bone marrow-, umbilical cord matrix and amniotic fluid-derived progenitor cells.. Vet Res Commun 2011 Feb;35(2):103-21.
                  doi: 10.1007/s11259-010-9457-3pubmed: 21193959google scholar: lookup
                41. Koch TG, Berg LC, Betts DH. Current and future regenerative medicine - principles, concepts, and therapeutic use of stem cell therapy and tissue engineering in equine medicine.. Can Vet J 2009 Feb;50(2):155-65.
                  pubmed: 19412395
                42. Violini S, Ramelli P, Pisani LF, Gorni C, Mariani P. Horse bone marrow mesenchymal stem cells express embryo stem cell markers and show the ability for tenogenic differentiation by in vitro exposure to BMP-12.. BMC Cell Biol 2009 Apr 22;10:29.
                  doi: 10.1186/1471-2121-10-29pubmed: 19383177google scholar: lookup
                43. Troyer DL, Weiss ML. Wharton's jelly-derived cells are a primitive stromal cell population.. Stem Cells 2008 Mar;26(3):591-9.
                  doi: 10.1634/stemcells.2007-0439pubmed: 18065397google scholar: lookup